Kalion, Inc.

📍 Milton, United States👥 9 employees💰 Last funded Jun 2021
Biotechnology Research🌐 kalioninc.com
Website LinkedIn
Kalion was founded to take on the significant challenge of commercializing important new molecules that could be derived in a greener manner and offer significant advantages over traditional oil-based molecules. Prof. Kristala Prather at MIT decided using the Department of Energy’s Top Value-Added Chemical from Biomass Report that glucaric acid offered a significant challenge but if successful it could offer a new platform chemical that could would have much to offer the world. Her success, with glucaric acid and the subsequent development at Kalion has created a high purity glucaric acid that now allows companies and researchers from other universities to fully exploited the unique properties of glucaric acid and related molecules.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2013–2021 · investors recorded per year
201312019220211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Kalion, Inc.?
Kalion, Inc. has 4 investors on record on gritt.io.
When did Kalion, Inc. last raise funding?
The most recent investment in Kalion, Inc. recorded on gritt.io was in June 2021.
What industry is Kalion, Inc. in?
Kalion, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kalion, Inc. based?
Kalion, Inc. is headquartered in Milton, United States.